Skip to content

Tevogen Bio Holdings Inc.

TVGN TVGNW

CIK 0001860871

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$27.04M
−91.4% YoY Q1 May 2026
EPS Diluted (TTM)
−$4.92
−130.9% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
−$10.45M
Q1 May 2026
Cash
$0
Q1 May 2026
Total Debt
$0
Q1 May 2026
Shares Outstanding
4.19M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings